InvestorsHub Logo
Followers 11
Posts 871
Boards Moderated 0
Alias Born 11/07/2013

Re: JimmyJams post# 74023

Monday, 03/30/2015 11:48:03 AM

Monday, March 30, 2015 11:48:03 AM

Post# of 80866
In all fairness to MusclePharm, they did increase sales 60% last year, and their Net Loss was much smaller than it has ever been. As an investor, you really shouldn't care whether Q4 sales were lower than Q3 sales etc. unless YoY sales stagnate/decline. In other words, who cares if they sell $60 million in Q1 and $45 million in Q4 as long as overall they hit their $210-$220 million guidance numbers for the year.

As has been mentioned on this board before, I believe that there is some seasonality to nutritional supplement sales. Q4 seems to be a time when people are more focused on family, travel, final exams, etc. than they are on supplements and fitness. In the same way, Q1 logically should be the best quarter as people try to get back in shape, the weather warms up and they are going outside once again. Who knows honestly, but that makes sense to me.

$MSLP - Proprietary ™